PABPN1
PABPN1 (poly(A) binding protein nuclear 1, also known as PAB2, PABP2 and OPMD) is an abundant nuclear RNA-binding protein that binds nascent poly(A) tails. It is required for efficient, progressive polyadenylation of mRNA precursors and sets the length of the poly(A) tail. Browse Assay Genie's current range of PABPN1 research reagents below, or read on for the biology behind the target.
PABPN1 is involved in 3'-end formation of mRNA precursors. It acts by supporting addition of a poly(A) tail of 200-250 nt to the upstream cleavage product. It stimulates poly(A) polymerase (PAPOLA), conferring processivity on tail elongation, increasing the polymerase's affinity for RNA and controlling the final tail length. The protein binds poly(A) and poly(G) with high affinity and may protect the poly(A) tail from degradation.
Beyond polyadenylation, PABPN1 is present at other stages of mRNA metabolism, including nucleocytoplasmic trafficking and nonsense-mediated decay (NMD). It is also a subunit of the trimeric poly(A) tail exosome targeting (PAXT) complex, which directs a subset of long polyadenylated RNAs for exosomal degradation. The RNA exosome is fundamental for RNA degradation in eukaryotic nuclei, and substrate targeting is aided by its cofactor MTREX, which links to RNA-binding protein adapters. PABPN1 also cooperates with SKIP to synergistically activate E-box-mediated transcription through MYOD1, and it may regulate muscle-specific gene expression.
At steady state the protein is mainly nuclear, in contrast to a different poly(A) binding protein that is cytoplasmic. UniProt lists nucleus, nuclear speckle and cytoplasm as locations. The human gene belongs to the RNA binding motif containing group; the protein is also named polyadenylate-binding protein 2. A GCG trinucleotide repeat at the 5' end of the coding region expands from the normal 6 copies to 8-13 copies in autosomal dominant oculopharyngeal muscular dystrophy (OPMD). Related pseudogenes exist on chromosomes 19 and X, and read-through transcription occurs between this gene and the upstream BCL2L2 gene. The mouse ortholog is Pabpn1.
PABPN1 is needed for progressive, efficient poly(A) tail synthesis and controls tail size, making it central to studies of pre-mRNA polyadenylation.
Expansion of the GCG repeat in the PABPN1 gene from 6 to 8-13 copies causes autosomal dominant OPMD.
As a subunit of the PAXT complex, PABPN1 helps direct long polyadenylated RNAs to the nuclear RNA exosome for degradation.
PABPN1 cooperates with SKIP to activate E-box-mediated transcription through MYOD1 and may regulate muscle-specific gene expression.
PABPN1 binds nascent poly(A) tails and stimulates poly(A) polymerase, giving processivity to tail elongation and controlling tail length at about 250 nt. It also acts in nucleocytoplasmic trafficking, nonsense-mediated decay and, as part of the PAXT complex, nuclear RNA degradation by the exosome.
PABPN1 is also called PAB2, PABP2 and OPMD, and UniProt names it polyadenylate-binding protein 2. Earlier HGNC names were poly(A)-binding protein, nuclear 1. The OPMD alias reflects the link between this gene and oculopharyngeal muscular dystrophy.
Expansion of a GCG repeat at the 5' end of the PABPN1 coding region, from 6 copies to 8-13, leads to autosomal dominant oculopharyngeal muscular dystrophy. The mouse ortholog is Pabpn1; check the datasheet of any product for its validated reactivity.
Poly(A) polymerase, RNA exosome cofactor and muscle transcription targets connected to PABPN1 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86U42; product specifications from Assay Genie datasheets.